Rothblatt Martine A's Form 4 filing
United Therapeutics Corp (UTHR) · filed May 18, 2026
- Accession no.
- 0001106578-26-000055
- Filed
- May 18, 2026
- Trade date
- May 15, 2026
- Filing delay
- 3 days
- Rule 10b5-1 plan
- Checked
This filing lists 8 non-derivative transactions and 1 derivative transaction. Open-market sales total $5.40M. It was filed 3 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Rothblatt Martine ACIK 0001106578 | Director, Officer (Chairperson & CEO) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| May 15, 2026 | Common Stock | MOption exerciseAcquired | +9,500 | $146.03 | +$1,387,285 | 50,013 | Direct | |
| May 15, 2026 | Common Stock | SSaleDisposed | −1,477 | $566.19F2 | −$836,262.63 | 48,536 | Direct | |
| May 15, 2026 | Common Stock | SSaleDisposed | −1,874 | $567.04F3 | −$1,062,632.96 | 46,662 | Direct | |
| May 15, 2026 | Common Stock | SSaleDisposed | −3,211 | $568.07F4 | −$1,824,072.77 | 43,451 | Direct | |
| May 15, 2026 | Common Stock | SSaleDisposed | −1,682 | $569.03F5 | −$957,108.46 | 41,769 | Direct | |
| May 15, 2026 | Common Stock | SSaleDisposed | −616 | $569.94F6 | −$351,083.04 | 41,153 | Direct | |
| May 15, 2026 | Common Stock | SSaleDisposed | −320 | $571.23F7 | −$182,793.6 | 40,833 | Direct | |
| May 15, 2026 | Common Stock | SSaleDisposed | −320 | $572.25F8 | −$183,120 | 40,513 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| May 15, 2026 | Common Stock | MOption exerciseDisposed | −9,500 | $0.00 | $0 | 221,410 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F2
This transaction was executed in multiple trades at prices ranging from $565.55 to $566.54. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Referenced by the price of 1 transaction in Table I.
- F3
This transaction was executed in multiple trades at prices ranging from $566.58 to $567.57. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Referenced by the price of 1 transaction in Table I.
- F4
This transaction was executed in multiple trades at prices ranging from $567.58 to $568.57. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Referenced by the price of 1 transaction in Table I.
- F5
This transaction was executed in multiple trades at prices ranging from $568.62 to $569.60. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Referenced by the price of 1 transaction in Table I.
- F6
This transaction was executed in multiple trades at prices ranging from $569.66 to $570.41. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Referenced by the price of 1 transaction in Table I.
- F7
This transaction was executed in multiple trades at prices ranging from $570.79 to $571.61. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Referenced by the price of 1 transaction in Table I.
- F8
This transaction was executed in multiple trades at prices ranging from $571.92 to $572.53. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Referenced by the price of 1 transaction in Table I.